Official name: NSTC/OSTP Framework for Nucleic Acid Synthesis Screening
Requires providers and manufacturers to implement screening for synthetic nucleic acids and equipment, identify sequences of concern, verify customer legitimacy, report suspicious orders, retain records, and enhance cybersecurity. Mandates adherence for federally funded research, with updates based on technological advances.
Analysis summaries, actor details, and coverage mappings were LLM-classified and may contain errors.
This is a binding regulatory framework with mandatory requirements for federally funded research. It uses mandatory language throughout ('should', 'will require', 'must'), establishes enforcement mechanisms through federal funding agencies, and includes reporting requirements to law enforcement (FBI).
The document has good coverage of approximately 6-8 subdomains, with strong focus on malicious actors (4.2 Cyberattacks and weapons development, 4.3 Fraud and manipulation), AI system security (2.2), competitive dynamics (6.4), governance failure (6.5), and system safety failures (7.2 Dangerous capabilities, 7.3 Lack of robustness). Coverage is concentrated in security, misuse prevention, and biosecurity domains.
The document primarily governs the Scientific Research and Development Services sector, with significant coverage of Health Care and Social Assistance, and some coverage of Professional and Technical Services. It applies to entities conducting life sciences research, including biotechnology companies, research institutions, and service providers in the synthetic biology space.
The document primarily covers the Deploy and Operate and Monitor stages of the AI lifecycle, with some coverage of Build and Use Model and Verify and Validate stages. It focuses on screening mechanisms for synthetic nucleic acid synthesis, which involves both the deployment of screening systems and ongoing operational monitoring of orders and customers.
The document does not explicitly mention AI models, AI systems, or specific AI categories like frontier AI, GPAI, or foundation models. However, it extensively discusses screening algorithms, software systems, and computational approaches for nucleic acid synthesis screening. The focus is on biosecurity screening mechanisms rather than AI governance per se, though these mechanisms may involve AI/ML technologies.
Office of Science and Technology Policy (OSTP); National Science and Technology Council (NSTC); President Biden (Executive Order); Department of Health and Human Services (2023 HHS Guidance); National Institute of Standards and Technology (NIST)
The framework was developed by OSTP as directed by President Biden's Executive Order on AI. It incorporates and supplements the 2023 HHS Guidance and directs NIST to engage with industry to develop technical standards.
Federal funding agencies; Office of Science and Technology Policy (OSTP); Assistant to the President for National Security Affairs (APNSA); Federal Bureau of Investigation (FBI); U.S. Department of Commerce Bureau of Industry and Security; Cybersecurity Infrastructure Security Agency (CISA)
Federal funding agencies enforce compliance through funding requirements. FBI receives reports of suspicious orders. Commerce Department handles export control violations. OSTP coordinates implementation across agencies.
OSTP-designated interagency group; National Institute of Standards and Technology (NIST); Federal funding agencies; Federal Bureau of Investigation (FBI)
An OSTP-designated interagency group will assess the scientific state of the art and recommend updates every two years. NIST will support development of technical standards. Federal agencies monitor compliance through funding oversight. FBI tracks reported suspicious orders.
Providers of synthetic nucleic acid sequences; Manufacturers of benchtop nucleic acid synthesis equipment; Biofoundries; Cloud labs; Core nucleic acid synthesis facilities; Contract research organizations (CROs); Third-party vendors
The framework explicitly targets providers who synthesize and distribute synthetic nucleic acids and manufacturers who produce benchtop synthesis equipment. It applies to various types of entities including biofoundries, cloud labs, core facilities, and CROs that provide these services.
10 subdomains (6 Good, 4 Minimal)